Cargando…
Botulinum toxin type A for genitofemoral neuralgia: A case report
Genitofemoral neuralgia is an uncommon pain disorder that could be resistant to conventional treatment. A 78-year-old woman with refractory right genitofemoral neuralgia was treated with BoNT/A subcutaneous injections; the treatment was performed three times with significant pain improvement, althou...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350489/ https://www.ncbi.nlm.nih.gov/pubmed/37465764 http://dx.doi.org/10.3389/fneur.2023.1228098 |
_version_ | 1785074143044042752 |
---|---|
author | Tereshko, Yan Enrico, Belgrado Christian, Lettieri Dal Bello, Simone Merlino, Giovanni Gigli, Gian Luigi Valente, Mariarosaria |
author_facet | Tereshko, Yan Enrico, Belgrado Christian, Lettieri Dal Bello, Simone Merlino, Giovanni Gigli, Gian Luigi Valente, Mariarosaria |
author_sort | Tereshko, Yan |
collection | PubMed |
description | Genitofemoral neuralgia is an uncommon pain disorder that could be resistant to conventional treatment. A 78-year-old woman with refractory right genitofemoral neuralgia was treated with BoNT/A subcutaneous injections; the treatment was performed three times with significant pain improvement, although temporary, and without adverse events. BoNT/A may be a promising alternative intervention in the setting of genitofemoral neuralgia refractory to oral and/or topical treatment. |
format | Online Article Text |
id | pubmed-10350489 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-103504892023-07-18 Botulinum toxin type A for genitofemoral neuralgia: A case report Tereshko, Yan Enrico, Belgrado Christian, Lettieri Dal Bello, Simone Merlino, Giovanni Gigli, Gian Luigi Valente, Mariarosaria Front Neurol Neurology Genitofemoral neuralgia is an uncommon pain disorder that could be resistant to conventional treatment. A 78-year-old woman with refractory right genitofemoral neuralgia was treated with BoNT/A subcutaneous injections; the treatment was performed three times with significant pain improvement, although temporary, and without adverse events. BoNT/A may be a promising alternative intervention in the setting of genitofemoral neuralgia refractory to oral and/or topical treatment. Frontiers Media S.A. 2023-07-03 /pmc/articles/PMC10350489/ /pubmed/37465764 http://dx.doi.org/10.3389/fneur.2023.1228098 Text en Copyright © 2023 Tereshko, Enrico, Christian, Dal Bello, Merlino, Gigli and Valente. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neurology Tereshko, Yan Enrico, Belgrado Christian, Lettieri Dal Bello, Simone Merlino, Giovanni Gigli, Gian Luigi Valente, Mariarosaria Botulinum toxin type A for genitofemoral neuralgia: A case report |
title | Botulinum toxin type A for genitofemoral neuralgia: A case report |
title_full | Botulinum toxin type A for genitofemoral neuralgia: A case report |
title_fullStr | Botulinum toxin type A for genitofemoral neuralgia: A case report |
title_full_unstemmed | Botulinum toxin type A for genitofemoral neuralgia: A case report |
title_short | Botulinum toxin type A for genitofemoral neuralgia: A case report |
title_sort | botulinum toxin type a for genitofemoral neuralgia: a case report |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350489/ https://www.ncbi.nlm.nih.gov/pubmed/37465764 http://dx.doi.org/10.3389/fneur.2023.1228098 |
work_keys_str_mv | AT tereshkoyan botulinumtoxintypeaforgenitofemoralneuralgiaacasereport AT enricobelgrado botulinumtoxintypeaforgenitofemoralneuralgiaacasereport AT christianlettieri botulinumtoxintypeaforgenitofemoralneuralgiaacasereport AT dalbellosimone botulinumtoxintypeaforgenitofemoralneuralgiaacasereport AT merlinogiovanni botulinumtoxintypeaforgenitofemoralneuralgiaacasereport AT gigligianluigi botulinumtoxintypeaforgenitofemoralneuralgiaacasereport AT valentemariarosaria botulinumtoxintypeaforgenitofemoralneuralgiaacasereport |